Asian Hotels and Properties PLC (COSE:AHPL.N0000)

Ligand Pharmaceuticals Income Statement

Financials in millions LKR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	10,362	10,772	8,417	4,095	1,790
Revenue Growth (YoY)	-3.80%	27.98%	105.55%	128.74%	-67.80%
Cost of Revenue	5,800	5,881	5,008	2,600	1,767
Gross Profit	4,562	4,891	3,408	1,495	23.36
Selling, General & Admin	3,420	3,229	2,505	1,634	1,828
Other Operating Expenses	706.48	1,061	827.63	400.96	259.71
Operating Expenses	4,127	4,289	3,333	2,035	2,088
Operating Income	435.28	601.18	75.4	-540.22	-2,065
Interest Expense	-196.57	-336.02	-372.32	-105.88	-21.7
Interest & Investment Income	19.28	11.49	13.61	7.49	33.51
Currency Exchange Gain (Loss)	0.57	14.32	-13.06	-1.69	-10.89
EBT Excluding Unusual Items	258.56	290.97	-296.37	-640.29	-2,064
Gain (Loss) on Sale of Assets	7.33	7.92	4.1	8.1	3.28
Asset Writedown	34.03	-89.9	154.39	124.85	-458.76
Pretax Income	307.76	212.34	-132.51	-459.23	-2,370
Income Tax Expense	222.44	134.68	200.25	48.62	-125.71
Earnings From Continuing Operations	85.32	77.66	-332.76	-507.85	-2,244
Minority Interest in Earnings	-130.13	-97.97	55.17	-2.32	463.33
Net Income	-44.8	-20.31	-277.59	-510.17	-1,781
Net Income to Common	-44.8	-20.31	-277.59	-510.17	-1,781
Shares Outstanding (Basic)	443	443	443	443	443
Shares Outstanding (Diluted)	443	443	443	443	443
EPS (Basic)	-0.10	-0.05	-0.63	-1.15	-4.02
EPS (Diluted)	-0.10	-0.05	-0.63	-1.15	-4.02
Free Cash Flow	425.35	-198.96	-427.39	-474.49	-1,163
Free Cash Flow Per Share	0.96	-0.45	-0.96	-1.07	-2.63
Dividend Per Share	0.500	-	-	-	-
Gross Margin	44.03%	45.40%	40.49%	36.51%	1.31%
Operating Margin	4.20%	5.58%	0.90%	-13.19%	-115.33%
Profit Margin	-0.43%	-0.19%	-3.30%	-12.46%	-99.47%
Free Cash Flow Margin	4.11%	-1.85%	-5.08%	-11.59%	-64.98%
EBITDA	1,137	1,197	575.3	-59.03	-1,538
EBITDA Margin	10.97%	11.12%	6.83%	-1.44%	-85.92%
D&A For EBITDA	701.52	596.07	499.9	481.18	526.46
EBIT	435.28	601.18	75.4	-540.22	-2,065
EBIT Margin	4.20%	5.58%	0.90%	-13.19%	-115.33%
Effective Tax Rate	72.28%	63.43%	-	-	-

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.